HIV and Brain Func.on. Tristan J Barber Research Physician St Stephen s AIDS Trust Chelsea and Westminster Hospital

Similar documents
How to Implement this Assessment in the Clinical Prac5ce?

International Symposium on. Barcelona, May 5 th and 6 th 2011

HIV Neurology Persistence of Cognitive Impairment Despite cart

Psychiatric Symptom Burden in Elders with HIV-Associated Neurocognitive Disorders

CAB 59: HIV and neurocogni5ve impairment

HIV DISEASE! Neurobehavioral! Neuromedical. Igor Grant, MD, FRCP(C) Director HIV Neurobehavioral Research Program University of California, San Diego

Central Nervous System Penetration of ARVs: Does it Matter?

Differential diagnosis between depression and neurocognitive impairment in HIV-infected persons

The Association Between Comorbidities and Neurocognitive Impairment in Aging Veterans with HIV

Sandra Weintraub, PhD Clinical Core Leader and Professor

Alzheimer s Disease and Demen<a

BHIVA Best of CROI Feedback Meetings. London Birmingham North West England Cardiff Gateshead Edinburgh

Dr Lucy Garvey. Imperial College Healthcare NHS Trust, London. 18 th Annual Conference of the British HIV Association (BHIVA)

National HIV Nurses Association (NHIVNA) Study Day in collaboration with the British Psychological Society Current Issues in HIV

COGNITIVE DYSFUNCTION AMONG HIV-POSITIVE PATIENTS ATTENDING CCC AT KENYATTA NATIONAL HOSPITAL

HIV & Women: Neurological Issues

HIV associated CNS disease in the era of HAART

Classification of Pediatric HIV CNS Disease: Comparison of CNS and Systemic Disease Markers of Children Treated in the HAART Era

Meningi&s in HIV NORTHWEST AIDS EDUCATION AND TRAINING CENTER

Neurocogni*ve Deficits in Older Cancer Pa*ents. Beatrice J. Edwards, MD, MPH Central Texas Veterans Healthcare System

Delirium & Dementia. Nicholas J. Silvestri, MD

The Brief Cogni-ve Assessment Tool (BCAT): A New Test Emphasizing Contextual Memory and Execu<ve Func<ons

DSM-5 and HAND. Diagnosis and Monitoring of HAND 10/6/2015. APA Institute on Psychiatric Services New York City

International Forum on HIV and Rehabilitation Research

HAND is Common and Important in Patients on ART

AIDS 2011, 3, 2011 RW

Dr Kate Childs. King s College Hospital NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Miss Jane Rowlands. Chelsea and Westminster Hospital, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

An Introduc+on to Stroke

Neuropsychological assessment in HIV/AIDS and its challenges in Galati County

Valutazione dei disturbi neurocognitivi e invecchiamento: non solo HAND. Workshop Nazionale CISAI Lecco 20 Marzo 2015

Emerging Considerations in neuroaids Internationally: Events in Acute and Early Infection

Other Perceptual Impairment

Detecting neurocognitive impairment in HIV-infected youth: Are we focusing on the wrong factors?

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body

Alzheimer Disease and Related Dementias

The Neurobiology of Au0sm. Computa0onal Psychiatry Seminar HS 14 Isabel Berwian

High rates of asymptomatic neurocognitive impairment are observed in perinatally HIV-infected adolescents

Dr Manisha Yapa. Chelsea and Westminster Hospital, London. 19 th Annual Conference of the British HIV Association (BHIVA)

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Chemo Brain and Fa.gue Chemotherapy Related Cogni:ve Impairment Chemotherapy Related Fa:gue. Alok Pant, MD Northwestern Medicine

Approach to HIV Associated Neurocognitive disorders (HAND)

Contemporary Issues in Adolescent Care. Mental Health

Geriatric Alterations Associated with Neurological Conditions

Neuropsychology and Parkinson s Disease. Erin Holker, Ph.D., ABPP Neuropsychology Laboratory

Case Presentation JF

HIV and Dementia. London Dementia Clinical Network 14 June Dr Patricia McNamara MB BCh BAO MRCP PhD. Locum Consultant Neurologist, NHNN

Anxiety Disorders. Diagnosis, Comorbidi4es and Management. Prepared by Dr. Aaron Silverman Dept. of Psychiatry, University of Toronto

Stroke in Human Immunodeficiency Virus (HIV) infected pa9ents

Thank you for joining us! Alzheimer s & African Americans We will begin momentarily. Please mute your phone/computer during the webinar.

Distribution and Effectiveness of Antiretrovirals in the Central Nervous System

Post doctor Rune Jonassen. Clinical Neuroscience Research Group, Department of Psychology, Oslo, Norway

HIV-1 Dual Infection and Neurocognitive Impairment

Womenʼs Health Day. Marsha McInnis, Family Member and President, NAMI Tri-Valley. September 25, 2008

Forget me not: providing care for people living with HIV and dementia (What does the future hold for our elderly HIV patients?)

Part 1 Parkinson s Disease. COGS 172: Brain Disorders and Cogni5on

The Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University

Diagnosis and Monitoring of HAND

Dr Ria Daly. Birmingham Heartlands Hospital. 18 th Annual Conference of the British HIV Association (BHIVA)

Consensus statement on Concussion in Sport. Zurich 2012

Depression in People Living with HIV/AIDS: Outcomes, Risks and Opportunities for Intervention

Management of a HIV-infected patient with a psychiatric disorder

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

The ABCs of Dementia Diagnosis

Neurocognitive Impairments in HIV: Natural History, Impacts on Everyday Functioning and Promising Interventions

Diagnosis and management of non-alzheimer dementias. Melissa Yu, M.D. Department of Neurology

A Biopsychosocial Approach to HIV- Associated Neurocogni9ve Disorders

SECTION 1: ABOUT HEPATITIS

Delirium, Dementia, and Amnestic Disorders. Dr.Al-Azzam 1

Original Article. J Young Pharm, 2016; 8(3): A multifaceted peer reviewed journal in the field of Pharmacy

Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London

Occupa&onal Therapy s Role in Children with ASD. Nicole Sheffield MS, OTR/L Chelsea Kraska MS, OTR/L

Measurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History

Plan for Today. Brain Injury: 8/4/2017. Effective Services for People Living with Brain Injury. What is it & what causes it?

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

Report Back from CROI 2010

HIV Associated Neurocognitive Disorders in the era of modern CART

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline

Assisted Living s Whole Brain Fitness: Can It Prevent Re-hospitalization?

Carol Manning, PhD, ABPP-CN Director, Memory Disorders Clinic University of Virginia

DSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602)

Clinical notes: Management of HAART in patients with HAND

Dementia. Assessing Brain Damage. Mental Status Examination

Safety of switching raltegravir 400mg twice daily to raltegravir 800mg once daily in virologically suppressed patients

HIV and Mental Health: An Update

Patient concerns. Will I grow old prematurely? Will I dement? Will I get heart disease?

What Are Neuroscience Core Concepts?

Dr Alan Winston. Imperial College Healthcare NHS Trust London. 7-8 October 2010, Queen Elizabeth II Conference Centre, London.

Demographic and Diagnostic Profile of Study Participants

What is dementia? What is dementia?

HIV-Associated Neurocognitive Disorders (HAND) Aroonsiri Sangarlangkarn, MD, MPH, Jonathan S. Appelbaum, MD, FACP

Patient selection for surgery: Hyperkinetic movement disorders

HIV AND CEREBROVASCULAR DISEASE: AN INTERSECTION OF EPIDEMICS

Psychiatric Treatment of the Concussed Athlete

How to Diagnose Early (Prodromal) Lewy Body Dementia. Ian McKeith MD, FRCPsych, F Med Sci.

HIV in the Brain MANAGING COMORBIDITIES IN PATIENTS WITH HIV

HIV Treatment as Prevention (TasP) Guideline and protocol

What is dementia? What is dementia?

Youth Mental Health and 22q11

Transcription:

HIV and Brain Func.on Tristan J Barber Research Physician St Stephen s AIDS Trust Chelsea and Westminster Hospital

HIV and the Brain When can HIV affect the brain? Seroconversion Long term infected (not on treatment) HIV vs. AIDS Long term infected (on treatment) Old age What can be measured, or not? How do we diagnose it?

Prac.cal aspects the history Nature of the onset Time course Type of memory failure If the history suggests that the cogni.ve problems are limited to memory alone, think of non HIV related causes of memory loss e.g. Alzheimer s Memory loss in the context of other cogni.ve changes increases suspicion of HAND aten.onal difficul.es psychomotor retarda.on execu.ve problems (difficulty with high level cogni.ve processing, such as planning, problem solving, and mul. tasking)

Important other considera.ons Other causes (may also present with slowly progressive cogni.ve changes) Sleep apnoea vitamin B12 deficiency thyroid disorders Acute onset memory changes are more o[en associated with strokes or infec.ons (herpes simplex encephali.s) Deficits of aten.on can occur in a number of se\ngs sleep depriva.on excessive stress fa.gue chronic pain medica.on side effects

HAND Triad of cogni.ve, motor and behavioural dysfunc.ons Memory Poor concentra.on, reading difficul.es Delayed speech with long pauses between words Poor thought, lack of emo.onal content and spontaneity Social withdrawal?depression Gait abnormali.es Frontal release signs, spas.city and brisk deep tendon reflexes

HAND Differen.al Diagnosis Psychiatric history common Substance abuse or withdrawal may mimic HAND Co infec.on with HCV and/or its treatment Combina.on of tests to exclude other causes Neuropsychological evalua.on Neuroimaging CSF

Older popula.on The prevalence of neurocogni.ve disorders among middle aged and older persons with HIV infec.on in the HAART era has not been well characterized Older HIV posi.ve persons have been found to have a higher prevalence of symptoms related to depression, alcohol abuse, and drug abuse than agematched HIV nega.ve controls, and these factors would probably influence the prevalence of neurocogni.ve problems

Modified from Ellis et al, Nat Rev Neurosci 2007 and Grant et al., CROI 2009 HAD HIV associated demen.a MND HIV associated mild neuro cogni.ve disorder ANI asymptoma.c neurocogni.ve impairment

Damaged brain may heal poorly Legacy of prior damage Nadir CD4 count CHARTER analysis suggest significant impact of nadir <350 Data too limited to test higher nadirs Implies earlier treatment could be helpful CROI 2010, Poster 429, Ellis, et al

Viral Load Plasma viral load is the strongest correlate of CSF viral load, emphasizing the importance of systemic HIV suppression for control of HIV in the nervous system Without ART, higher CSF VLs also correlated with older age and more advanced current and past immunosuppression With ART, detectable CSF VLs were associated with worse adherence, worse es.mated an.retroviral penetra.on, and non white ethnicity The mechanisms by which age and ethnicity influence CSF VL are unknown Among people not taking ART, worse global neurocogni.ve performance was associated with having CSF VLs that were at least as high as plasma VLs

Prac.cal Trailmaking Can t show or do prac.cally as may cause learning effect

Anxiety and Depression

Conclusions Most important diagnose neurocogni.ve decline (HAND and other HIV related issues) vs. other problems that may present with similar features Not certain if it is all about ART and CNS penetra.on further studies needed Aspects of mood, diet, physical ac.vity, independence, adherence are most important issues

BHIVA 2011 - Recent Data 101 patients on stable antiretroviral therapy without any obvious neurological symptoms or other illnesses All had HIV for more than six months. Two types of test 20-minute computerised cognitive assessment test Cogstate and the International HIV Dementia Scale (IHDS) Neurocognitive impairment was defined as scores more than one standard deviation below the mean acompared to age-matched population data in at least two areas of functioning

BHIVA 2011 - Recent Data Median age 53 Majority (77%) white men HIV-positive for an average of 14 years Mean CD4 count of 559 and lowest-ever CD4 count (nadir) of 185 A high proportion 25% - had hepatitis C Overall rate of neurocognitive impairment was 19%, only 3% above general population Fine muscular movement, multitasking and executive function (prioritising and planning) were particularly impaired CD4 nadir was associated with a high IHDS score